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Abstract Sequence data was obtained from the capsid
(ORF-2) and the polymerase (ORF-lb) genes of 23 turkey
astrovirus (TAstV) isolates collected from commercial
turkey flocks around the United States between 2003 and
2004. A high level of genetic variation was observed
among the isolates, particularly in the capsid gene, where
nucleotide sequence identity among them was as low as
69%. Isolates collected on the same farm, on the same day,
but from different houses could have as little as 72%
identity between their capsid gene sequences when com-
pared. Phylogenetic analysis of the capsid gene revealed no
clear assortment by geographic region or isolation date.
The polymerase gene was more conserved with between 86
and 99% nucleotide identity and did assort in a geographic
manner. Based on differing topologies of the capsid and
polymerase gene phylogenetic trees, TAstV appears to
undergo recombination.
Keywords Turkey astrovirus Æ Sequencing Æ
Phylogenetic analysis Æ Recombination
Astroviruses are small, non-enveloped, positive sense
ssRNA viruses that are associated with enteric disease in
humans [1] and numerous mammalian and avian species
[1–4]. The astrovirus genome is approximately 7000 nt
long and has a 5¢ untranslated region followed by three open
reading frames (ORF’s), a 3¢ untranslated region, and a
poly-A tail. Two ORF’s, ORF-1a and ORF-1b, are linked by
a translational frame-shift and encode the non-structural
proteins [5, 6]. Analysis of ORF-1b indicates that it encodes
an RNA-dependent RNA polymerase [7]. This region of the
astrovirus genome is the most conserved gene between the
mammalian and the avian astroviruses, as well as among the
avian astroviruses [8]. ORF-2 encodes the capsid protein,
which is the primary antigenic determinant of the virus.
Turkey astrovirus (TAstV) was first described in 1980
by McNulty et al. [9] in the United Kingdom, and the first
isolate of TAstV in the United States was identified in 1985
[10]. A second TAstV type, which was antigenically and
genetically distinct from the previously identified United
States isolates (TAstV-1), was isolated in 1996. This and
similar isolates have been designated TAstV-2 [8, 11, 12].
The entire genome sequence of the prototype TAstV-2
isolate, NC/96, has been reported and bears many similar
features to human astroviruses (HAstV’s) [11]. Based on
epidemiological studies using electron microscopy as many
as 78% of turkey flocks presenting enteritis have TAstV in
their feces [13]. For this reason TAstV-2 is believed to be
one of the etiological agents of poult enteritis complex, an
economically important polymicrobial disease character-
ized by enteritis and, in severe cases, high mortality in
commercial turkeys under 6 weeks of age [14].
Nucleotide sequence accession numbers. The TAstV nucleotide se-
quences presented in this article have been submitted to GenBank
under Accession Numbers: DQ066553–DQ066575 for the capsid
sequences and DQ066576–DQ066598 for the polymerase sequences.
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In this study, the genetic diversity of TAstV-2 isolates
collected in the US was evaluated by comparative analysis
of the polymerase gene (ORF-1b) and capsid (ORF-2) gene
sequences. Intestinal contents were collected from turkeys
between 1 and 10 weeks of age from flocks in North Car-
olina (NC), Virginia (VA), California (CA) and Texas (TX)
during 2003 and 2004. Specimens were collected primarily
from flocks affected with enteritis, however, two isolates
(NC/SEP/A40/03 and NC/SEP/A252/04) came from flocks
described as healthy and performing well. Total RNA was
extracted from intestinal contents by diluting 200 ll of the
sample in 1.2 ml of PBS, homogenizing and performing a
clarification by centrifugation. Then 250 ll of the super-
natant was used for RNA extraction with Trizol LS reagent
(Invitrogen Inc., Carlsbad, CA) in accordance with the
manufacturer’s instructions.
Samples were initially screened for TAstV by real-time
reverse transcription-polymerase chain reaction (RRT-
PCR) as previously described [15]. Portions of the poly-
merase (nucleotide position 4077–4880 by NC/96 num-
bering) and capsid genes (nucleotide position 6208–7035
by NC/96 numbering) of samples positive for TAstV by
RRT-PCR were amplified by standard RT-PCR with the
MKCap and MKPol primers as previously reported [16]
(Fig. 1) with the Qiagen OneStep RT-PCR kit (Qiagen
Inc., Valencia CA) in accordance with the kit instructions,
without Q solution and with 0.6 lM of each primer. The
region between the previously described segments of the
polymerase and capsid genes of selected isolates was also
amplified by RT-PCR. RT-PCR products were analyzed by
agarose gel electrophoresis and amplicons of the correct
size were excised, extracted with the QIAquick gel
extraction kit (Qiagen Inc., Valencia CA) and directly se-
quenced with the BigDye terminator kit (Applied Biosys-
tems, Foster City, CA) and were subsequently run on an
ABI 3730 (Applied Biosystems, Foster City, CA). All RT-
PCR products were also cloned with the TOPO TA cloning
system (pCR2.1 vector) (Invitrogen Life Technologies,
Chicago, IL) in accordance with the kit instructions. DNA
plasmids containing the insert were prepared with the
Qiaprep spin miniprep kit (Qiagen Inc., Valencia, CA).
Plasmids were sequenced as described above.
Sequences were aligned with ClustalW (DNASTAR
Inc., Madison, WI) and phylogenetic analysis was per-
formed with PAUP*4. 0b10 using the maximum parsimony
tree building method with 1000 bootstrap replicates by
heuristic search (Sinauer Associates Inc., Sunderland,
MA). The following previously reported TAstV capsid and
polymerase sequences from GenBank were included in
the phylogenetic analysis: TAstV-1 complete genome
(NC002470), TAstV-2 complete genome (NC005790)
(NC/96), TAstV-2 polymerase partial sequence (AY320042)
(TEVL-NC88), TAstV-2 capsid partial sequence
(AY320042) (TEVL-NC88), and TAstV Ohio 2001 entire
capsid sequence (AY769616).
Nucleotide (nt) and amino acid (aa) sequences of the
polymerase gene were more conserved than the capsid
gene among the TAstV isolates, which is consistent with
what has been observed for HAstV’s [17, 18]. However,
based on at least 10% nt divergence, the polymerase gene
assorted into 2 groups (Fig. 2). Group 1 contained all re-
cent isolates from Virginia (VA), North Carolina (NC) and
Texas (TX), although the isolates from TX formed a sub-
clade together. Among group 1 isolates there was nt sim-
ilarity of between 94 and 100% and a predicted aa identity
of between 97.5 and 100%. Group 2 consisted of all iso-
lates from California (CA), and the two older NC isolates,
NC/96 and TELV-NC88. This relationship suggests an
epidemiological link, although no clear link is known.
Within group 2 the nt similarity was between 96.7 and
98.9%. Between groups 1 and 2 there was at least 11.6% nt
divergence. The nt identity with TAstV-1 was between
39.5 and 48.0% and the deduced aa identity between all
isolates and TAstV-1 was less than 62.5%.
Analysis of the nt and deduced aa sequences of the
capsid region revealed substantial variation among the
isolates (Fig. 2). Phylogenetically, the isolates assorted into
9 groups based on greater than 10% nt sequence divergence
between groups. There was no clear assortment due to
geographic origin or year of isolation. Within the groups
the nt identity was as high as 99.7% (100% aa identity) and
the most distantly related isolates, regardless of group, had
64.9% nt identity (73.6% aa identity). TAstV-1 had less
than 47.8% aa identity with all the isolates studied.
Sequence variation among the capsid genes of TAstV
was greater than expected and is higher than what has been
reported for HAstV [19]. The sequence varies not only
due to substitutions throughout the gene, but also with
Fig. 1 Diagram of the turkey astrovirus genomic organization and location of primers used for amplification of segments of the polymerase and
capsid genes. Numbers within the diagram represent the predicted start and stop sites. Primer sites are indicated with arrows
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insertions and deletions which occur at several positions
(Fig. 3). The Ohio 2001 isolate contained a unique 5 aa
deletion. The isolates in phylogenetic groups 3, 4, 5 and 6
had a 2 aa insertion, and the 2 isolates from group 7 had a
4 aa insertion. This amount of variation would suggest
that there is antigenic variation among the isolates, as
Walter et al. [19] established that for HAstV that when
two strains had less than 95% nucleotide homology they
would constitute strains that could be serologically dis-
tinguished. However, due to the lack of an in vitro
Fig. 3 ClustalW amino acid alignment of selected TAstV isolate capsid gene sequences. The positions where amino acids are identical are
indicated as (.) and where amino acids are missing are indicated as (-). The boxed areas indicate amino acid insertions or deletions
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propagation system, antigenic analysis is unfeasible at this
time.
Importantly, the topologies of the capsid and polymer-
ase nt and aa trees differed. A particularly interesting
example of this is given by the distinct assortment of the
capsid and polymerase genes from isolates collected from
different houses on the same farm, on the same day. Two
sets of isolates fall into this category; the first being NC/
SEP-A252/04 and NC/SEP-A253/04, and the second set
being NC/SEP-A254/04 and NC/SEP-A255/04. The poly-
merase genes of each set assort together and share
approximately 96% nt identity with the other isolate from
the same farm. However, the capsid genes from the first set
assort separately into groups 3 and 6 sharing only 85.1% nt
identity, and the second set assort separately into groups 1
and 7 and have only 72.1% nt identity.
The irregular assortment of the polymerase and capsid
genes of these and other individual viruses suggests that
recombination may be occurring among TAstV isolates in
the field. Genome recombination has been reported for
several positive-sense, single-stranded RNA viruses
including: astroviruses, coronaviruses, enteroviruses, and
caliciviruses [17, 20–28]. To address the issue of recom-
bination in more detail, ten isolates were sequenced in the
intergenic region and analyzed. The 2.9 kb nucleotide
sequence spanning the amplified region of the polymerase
and capsid genes of four of these isolates (VA/SEP/A33/
03, CA/SEP/A269/04, NC/SEP/A222/03 and TX/SEP/
A311/04) and the TAstV-2 (NC/96) prototype was selected
to demonstrate results. The SimPlot computer program [29]
was used to analyze the alignment of the five TAstV iso-
lates using a window size of 200 nucleotides that was
moved along in 20-nucleotide steps. The percent identity
was calculated for each window and plotted in a line chart.
The chart showed that VA/SEP/A33/03 shared a low level
of sequence identity in the polymerase region when com-
pared to TAstV-2 NC/96 and a constantly high level of nt
identity in the capsid region with the same virus. A single
cross of the two curves was observed 200 nt after the ORF-
1b/ORF-2 junction (Fig. 4). The likelihood analysis of
recombination in DNA (LARD) program [30] was used to
identify the point of recombination between VA/SEP/A33/
03 and TAstV-2 NC/96. The predicted site was at nucle-
otide 1120 of the region amplified. This recombination site
was different than the site suggested with other RNA
viruses, where the recombination site is frequently found at
the conserved region of the ORF’s junction [19, 24, 27].
When isolate CA/SEP/A269/04 and TAstV-2 NC/96 were
compared, no significant change of sequence identity was
observed between the polymerase and capsid regions. When
isolates NC/SEP/A222/03 and TX/SEP/A311/04 were
compared with TAstV-2 a low level of sequence identity in
the polymerase and capsid regions was observed, although
the junction region and the region from nucleotides 200 and
900 of the capsid gene had higher sequence identity.
Recombination in ssRNA viruses is an important mech-
anism for generating diversity in enteroviruses such as polio
[21], and also caliciviruses [27]. Walter et al. [20] reported
Fig. 4 Nucleotide identity plot of the 2.9 kb region comprising the
amplified polymerase and capsid regions of TAstV-2 compared with
TAstV isolates VA/SEP/A33/03 (33), NC/SEP/A222/03 (222), CA/
SEP/A269/04 (269), TX/SEP/A311/04 (311). The bar below the plot
represents the regions corresponding to ORF-1b (polymerase) and
ORF-2 (capsid). The arrow indicates the point after the recombination
site (nucleotide 1120) identified by LARD analysis
Virus Genes (2006) 32:187–192 191
123
that phylogenetic analysis of different regions of human
astroviruses provided contradictory genotyping and dem-
onstrated the occurrence of recombination between strains.
Recombination requires concomitant infection of one host
with two strains. Natural co-infection with two strains is
certainly feasible due to the high incidence of TAstV-2 in
commercial turkeys. The preferred mechanism of recom-
bination among ssRNA viruses is a copy-choice mechanism
where the polymerase enzyme switches from copying one
RNA molecule (donor template) to another (acceptor tem-
plate) without releasing the nascent strand [31].
Antigenic variation among astroviruses in different
species has been well described. Eight serotypes of HAstV
and three serotypes of bovine astrovirus have been defined
[1] and are believed to evolve to some extent as immu-
nological escape mutants. Interestingly, turkeys do not
seem to elicit a good antibody response to the TAstV [32],
which may explain why the virus circulates as multiple
discrete sub-lineages similar to HIV [33, 34] as opposed to
homogenous populations which undergo gradual antigenic
drift with host immune pressure thereby assorting chro-
nologically and geographically [35, 36].
In conclusion, comparative analysis of 23 TAstV isolate
capsid genes revealed nine distinct genotypes circulating in
the US during 2003 and 2004. Multiple TAstV genotypes
were often present in one geographical region and even on
the same farm. Although the polymerase gene assorted into
two phylogenetic groups, this gene was more conserved and
may be able to serve as a target for nucleic acid detection
tests. Furthermore, evidence of recombination was shown
by different topologies of the polymerase and capsid gene
phylogenetic trees and by SimPlot analysis. It is also
interesting to note that the two isolates collected from
healthy flocks grouped together. Finally, extensive genetic
variation, and the likely consequential antigenic variation,
has practical implications for virus detection methods,
vaccine development and epidemiological studies.
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